A Bcl-6 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

OICR-12694

Item No. 44288

Technical Information
Formal Name
3-[5-(aminocarbonyl)-2,3-difluoro-4-hydroxyphenyl]-N-[3-chloro-6-[(2S)-2,4-dimethyl-1-piperazinyl]-2-fluoro-4-pyridinyl]-4,6,7,8-tetrahydro-4-oxo-1H-dipyrrolo[1,2-a:2′,3′-d]pyrimidine-1-acetamide
CAS Number
2360625-97-2
Synonyms
  • JNJ-65234637
Molecular Formula
C29H28ClF3N8O4
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
NC(C(C=C1C2=CN(CC(NC3=C(Cl)C(F)=NC(N4CCN(C[C@@H]4C)C)=C3)=O)C5=C2C(N6CCCC6=N5)=O)=C(C(F)=C1F)O)=O
InChi Code
InChI=1S/C29H28ClF3N8O4/c1-13-10-38(2)6-7-40(13)19-9-17(22(30)26(33)36-19)35-20(42)12-39-11-16(14-8-15(27(34)44)25(43)24(32)23(14)31)21-28(39)37-18-4-3-5-41(18)29(21)45/h8-9,11,13,43H,3-7,10,12H2,1-2H3,(H2,34,44)(H,35,36,42)/t13-/m0/s1
InChi Key
LGAFZGSECXDYIR-ZDUSSCGKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    OICR-12694 is an inhibitor of Bcl-6.1 It binds to the BTB domain on Bcl-6 (Kd = 5 nM in a surface plasmon resonance (SPR) assay). OICR-12694 decreases transcription of Bcl-6-targeted genes in a reporter assay using SU-DHL-4 cells (EC50 = 89 nM). It reduces the proliferation of Karpas-422 large B cell lymphoma cells (IC50 = 92 nM).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mamai, A., Chau, A.M., Wilson, B.J., et alDiscovery of OICR12694: A novel, potent, selective, and orally bioavailable BCL6 BTB inhibitor. ACS Med. Chem. Lett. 14(2), 199-210 (2023).